Get notified when VIR files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsVir Biotechnology CMO Mark Eisner to step down April 24; successor search underway
Filed April 10, 2026 · Period ending April 7, 2026 · ~1 min read
Key Changes
-
medium
Chief Medical Officer Mark Eisner will leave his role effective April 24, 2026, after notifying the company on April 7. No reason for departure disclosed.
Item 5.02 verify on EDGAR → -
medium
Company has initiated a search for Eisner's successor. No interim CMO named in the filing.
8-K: Officer Departure verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (CAG 10-K) is open in full — no account needed.
Partner
Trade VIR commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify